Mannose-binding lectin levels and infections in children after allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 45, Issue 2, 2010, Pages 289-293

  Chaudhry, S H ^a   Chaudhry, S ^a   Jansen Hoogendijk, A M ^a   Jol Van Der Zijde, C M ^a   Van Tol, M J D ^a   Roos, A ^a   Bredius, R G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Allogeneic hematopoietic SCT; Children; Infections; Mannose binding lectin

Indexed keywords

COTRIMOXAZOLE; MANNOSE BINDING LECTIN;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; BLACKFAN DIAMOND ANEMIA; BLOOD DISEASE; CHILD; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUNTER SYNDROME; IMMUNOPATHOLOGY; INBORN ERROR OF METABOLISM; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PARASITOSIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECIPIENT; SHWACHMAN SYNDROME; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFECTION; MANNOSE-BINDING LECTIN; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 76749142889     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.159     Document Type: Article

References (19)

1. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol 2006; 67: 247-256.
2. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496-1505.
3. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180: 86-99.
4. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358: 614-618.
5. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358: 637-638.
6. Schlapbach LJ, Aebi C, Otth M, Luethy AR, Leibundgut K, Hirt A et al. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer 2007; 49: 11-16.
7. Mullighan CG, Heatley S, Doherty K, Szabo F, Grigg A, Hughes TP et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524-3529.
8. Mullighan CG, Heatley SL, Danner S, Dean MM, Doherty K, Hahn U et al. Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation. Blood 2008; 112: 2120-2128.
9. Rubnitz JE, Howard SC, Willis J, Pui CH, Pounds S, Hayden RT. Baseline mannose binding lectin levels may not predict infection among children with leukemia. Pediatr Blood Cancer 2008; 50: 866-868.
10. Kilpatrick DC, McLintock LA, Allan EK, Copland M, Fujita T, Jordanides NE et al. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapyrelated infections. Clin Exp Immunol 2003; 134: 279284.
11. Aittoniemi J, Miettinen A, Laine S, Sinisalo M, Laippala P, Vilpo L et al. Opsonising immunoglobulins and mannanbinding lectin in chronic lymphocytic leukemia. Leuk Lymphoma 1999; 34: 381-385.
12. Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129: 408-414.
13. Kilpatrick DC, Stewart K, Allan EK, McLintock LA, Holyoake TL, Turner ML. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant 2005; 35: 179-181.
14. Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005; 5: 1361-1366.
15. Kilpatrick DC. Mannan-binding lectin and stem cell transplantation. In: Karl B Neumann (ed). Hematopoietic Stem Cell Transplantation Research Advances. Nova Science Publishers Inc.: Hauppauge, New York, 2008, pp 1-6.
16. Eisen DP, Dean MM, Boermeester MA, Fidler KJ, Gordon AC, Kronborg G et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008; 15: 510-516.
17. Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC et al. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 2004; 34: 2589-2598.
18. Berger SP, Roos A, Mallat MJ, Schaapherder AF, Doxiadis II, van Kooten C et al. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2007; 18: 2416-2422.
19. Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Molec Immunol 2006; 43: 86-96.